Bio-Techne TECH Cash Flow Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $51.05M+34.3% | $38.01M-0.5% | $38.19M— | —— | $22.59M-35.3% | ||
| $24.17M-2.2% | $24.71M+1.5% | $24.34M-10.2% | $27.11M-1.7% | $27.57M+1.8% | ||
| $10.5M-24.8% | $13.96M+19.5% | $11.68M+157% | $4.55M-60.1% | $11.39M-22.6% | ||
| $2.84M— | —— | $5.28M+116% | -$32.28M-497% | -$5.41M+33.0% | ||
| —— | $1.94M-86.2% | $14M+112% | $6.6M— | $0-100% | ||
| —— | -$5.99M-183% | -$2.12M+84.1% | -$13.32M-2,083% | -$610K— | ||
| —— | —— | -$22.1M-750% | $3.4M-58.1% | $8.12M-33.0% | ||
| —— | —— | $1M+576% | $148K-33.3% | $222K— | ||
| —— | -$2.88M-657% | -$380K-105% | $7.16M+5.0% | $6.81M— | ||
| —— | —— | -$27.4M-267% | $16.38M+611% | $2.31M+157% | ||
| -$2.37M— | —— | $2.05M— | —— | —— | ||
| $31.26M+3,422% | -$941K+95.8% | -$22.39M+22.4% | -$28.86M— | —— | ||
| $86.66M+5.2% | $82.41M+199% | $27.59M-71.9% | $98.2M+139% | $41.12M-51.2% | ||
| $9.09M+53.5% | $5.92M+10.4% | $5.36M+9.7% | $4.89M-51.7% | $10.12M+48.4% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$5.82M+1.8% | -$5.92M-1,079% | $605K— | $0+100% | -$8.87M-76.3% | ||
| $12.52M+0.4% | $12.47M+0.2% | $12.44M+0.5% | $12.39M-1.5% | $12.58M-1.2% | ||
| —— | —— | $24K-100.0% | $100.06M0.0% | $100.05M— | ||
| $60M+50.0% | $40M-13.0% | $46M-8.0% | $50M+525% | $8M— | ||
| $29.96M+532% | $4.74M-79.8% | $23.5M+277% | $6.23M-58.1% | $14.87M+168% | ||
| $157K-87.5% | $1.26M-86.4% | $9.23M+3,845% | $234K-19.6% | $291K-71.3% | ||
| -$42.72M+12.8% | -$48.99M-10.8% | -$44.2M+51.1% | -$90.45M-32.9% | -$68.05M+18.8% | ||
| -$1.19M— | —— | -$1.21M-109% | $13.36M+1,336% | -$1.08M+80.2% | ||
| $36.94M+32.3% | $27.92M+262% | -$17.22M-180% | $21.52M+158% | -$36.88M— | ||
| $2.99M-25.1% | $3.99M-17.3% | $4.82M— | —— | $4.4M-4.9% | ||
| $5.67M-3.4% | $5.87M-80.9% | $30.81M— | —— | $18.31M-13.3% | ||
| —— | —— | —— | $11.35M+9,359% | $120K-96.8% | ||
| -$739K-772% | $110K-62.6% | $294K-73.4% | $1.11M+288% | -$589K-1,380% | ||
| —— | —— | —— | $197K+8.8% | $181K-2.2% | ||
| $31.26M+3,422% | -$941K+95.8% | -$22.39M+22.4% | -$28.86M— | —— | ||
| —— | —— | -$22.1M-750% | $3.4M-58.1% | $8.12M-33.0% | ||
| —— | -$2.88M-657% | -$380K-105% | $7.16M+5.0% | $6.81M— | ||
| -$839K+3.3% | -$868K+4.8% | -$912K-598% | $183K+1,730% | $10K-78.7% | ||
| —— | —— | $6.79M— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | $4.62M+602% | $658K— | —— | ||
| —— | —— | —— | $1.82M0.0% | $1.82M0.0% | ||
| -$1.19M— | —— | -$1.21M-109% | $13.36M+1,336% | -$1.08M+80.2% | ||
| —— | —— | —— | $66M+73.7% | $38M— | ||
| -$2.37M— | —— | $2.05M— | —— | —— | ||
| $77.58M+1.4% | $76.49M+244% | $22.22M-76.2% | $93.31M+201% | $31M-60.0% | ||
| $77.58M+1.4% | $76.49M+244% | $22.22M-76.2% | $93.31M+201% | $31M-60.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Bio-Techne generate?
- Bio-Techne (TECH) generated $294.9M in operating cash flow over the trailing twelve months.
- What is Bio-Techne's free cash flow?
- After $25.3M of capital expenditures, Bio-Techne's free cash flow was $269.6M over the trailing twelve months, up 22.1% year over year.
- Where does Bio-Techne's cash flow data come from?
- Every line is extracted from Bio-Techne's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
